Gritstone bio Inc GRTS:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 AM EDT
0.77quote price arrow up+0.0089 (+1.1691%)
Volume
6,819
Close
0.7613quote price arrow down-0.0086 (-1.117%)
Volume
1,822,629
52 week range
0.67 - 3.33
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.7613
  • 52 Week High3.33
  • 52 Week High Date10/10/23
  • 52 Week Low0.67
  • 52 Week Low Date04/16/24

Key Stats

  • Market Cap82.654M
  • Shares Out108.57M
  • 10 Day Average Volume2.88M
  • Dividend-
  • Dividend Yield-
  • Beta0.59
  • YTD % Change-62.68

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.7613
  • 52 Week High3.33
  • 52 Week High Date10/10/23
  • 52 Week Low0.67
  • 52 Week Low Date04/16/24
  • Market Cap82.654M
  • Shares Out108.57M
  • 10 Day Average Volume2.88M
  • Dividend-
  • Dividend Yield-
  • Beta0.59
  • YTD % Change-62.68

RATIOS/PROFITABILITY

  • EPS (TTM)-1.57
  • P/E (TTM)-0.48
  • Fwd P/E (NTM)-0.74
  • EBITDA (TTM)-135.034M
  • ROE (TTM)-187.15%
  • Revenue (TTM)15.645M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-926.13%
  • Debt To Equity (MRQ)288.81%

EVENTS

  • Earnings Date08/07/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Gritstone bio Inc

 

Profile

MORE
Gritstone bio, Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers next generation cancer and infectious disease immunotherapy candidates. It has developed two vectors that it deploys with the aim of eliciting the desired immune response: self-amplifying mRNA (samRNA) and chimpanzee adenovirus (ChAd). Its two oncology programs in clinical-stage development are GRANITE, individualized neoantigen-based immunotherapy, and SLATE, an...
Elaine Jones Ph.D.
Independent Chairman of the Board
Andrew Allen M.D., Ph.D.
President, Chief Executive Officer, Director
Erin Jones
Chief Operating Officer, Executive Vice President
Vassiliki Economides
Chief Financial Officer, Executive Vice President
Vijay Yabannavar Ph.D.
Executive Vice President, Chief Technical Development Officer
Address
5959 HORTON STREET, SUITE 300
Emeryville, CA
94608
United States

Top Peers

SYMBOLLASTCHG%CHG
JAGX
Jaguar Health Inc
0.2749-0.0154-5.3049%
CARM
Carisma Therapeutics Inc
1.46-0.02-1.35%
CRIS
Curis Inc
15.69+0.03+0.19%
ALGS
Aligos Therapeutics Inc
0.6915+0.0069+1.0079%
AFMD
Affimed NV
5.24-0.02-0.38%